Literature DB >> 22144403

Split liver transplantation using extended right grafts: the natural history of segment 4 and its impact on early postoperative outcomes.

Ailton Sepulveda1, Olivier Scatton, Hadrien Tranchart, Hervé Gouya, Fabiano Perdigao, Fabien Stenard, Denis Bernard, Filomena Conti, Yvon Calmus, Olivier Soubrane.   

Abstract

Split liver transplantation (SLT) using extended right grafts is associated with complications related to ischemia of hepatic segment 4 (S4), and these complications are associated with poor outcomes. We retrospectively analyzed 36 SLT recipients so that we could assess the association of radiological, biological, and clinical features with S4 ischemia. The overall survival rates were 84.2%, 84.2%, and 77.7% at 1, 3, and 5 years, respectively. The recipients were mostly male (24/36 or 67%) and had a median age of 52 years (range = 13-63 years), a median body mass index of 22.9 kg/m(2) (range = 17.3-29.8 kg/m(2) ), and a median graft-to-recipient weight ratio of 1.3% (range = 0.9%-1.9%). S4-related complications were diagnosed in 22% of the patients (8/36) with a median delay of 22 days (range = 10-30 days). Secondary arterial complications were seen in 3 of these patients and led to significantly decreased graft survival in comparison with the graft survival of patients without complications (50.0% versus 85.6%, P = 0.017). Patients developing S4-related complications had significantly elevated aspartate aminotransferase (AST) levels (>1000 IU/L) on postoperative day (POD) 1 and elevated gamma-glutamyl transpeptidase (GGT) levels (>300 IU/L) on PODs 7 and 10 (P < 0.05). These AST and GGT elevations conferred a significantly high risk of developing these complications (odds ratio = 42, 95% confidence interval = 4-475, P < 0.05). The ischemic volume of S4 was extremely variable (0%-95%) and did not correlate with S4-related complications. In conclusion, our results suggest that S4-related complications are risk factors for worse graft survival, and the development of these complications can be anticipated by the early identification of a specific biological profile and a routine radiological examination.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22144403     DOI: 10.1002/lt.22479

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  5 in total

Review 1.  Current status and perspectives in split liver transplantation.

Authors:  Andrea Lauterio; Stefano Di Sandro; Giacomo Concone; Riccardo De Carlis; Alessandro Giacomoni; Luciano De Carlis
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

2.  Long-term results after adult ex situ split liver transplantation since its introduction in 1987.

Authors:  Harald Schrem; Moritz Kleine; Tim Oliver Lankisch; Alexander Kaltenborn; Lampros Kousoulas; Lea Zachau; Frank Lehner; Jürgen Klempnauer
Journal:  World J Surg       Date:  2014-07       Impact factor: 3.352

3.  A Novel Surgical Technique to Assure Donor and Recipient Safety: Pyloric to Segment 4 Arterial Reconstruction.

Authors:  Andres Fraile; Luis M Mercado; Hugo Paladini; Diego A Ramisch; Valeria Descalzi; Silvina Yantorno; Pablo A Farinelli; Pablo Barros Schelotto; Gabriel E Gondolesi
Journal:  Transplant Direct       Date:  2020-12-15

4.  Prognosis of Split Liver Transplantation Compared with Whole Liver Transplantation in Adult Patients: Single-center Results under the Korean MELD Score-based Allocation Policy.

Authors:  Gil Chun Park; Shin Hwang; Gi Won Song; Dong Hwan Jung; Tae Yong Ha; Chul Soo Ahn; Deok Bog Moon; Ki Hun Kim; Young In Yoon; Woo Hyoung Kang; Hwui Dong Cho; Jin Uk Choi; Minjae Kim; Byeong Gon Na; Sang Hoon Kim; Sung Gyu Lee
Journal:  J Korean Med Sci       Date:  2020-09-21       Impact factor: 2.153

5.  Fates of retained hepatic segment IV and its prognostic impact in adult split liver transplantation using an extended right liver graft.

Authors:  Yong-Kyu Chung; Shin Hwang; Chul-Soo Ahn; Ki-Hun Kim; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Gil-Chun Park; Young-In Yoon; Woo-Hyoung Kang; Hwui-Dong Cho; Jin Uk Choi; Minjae Kim; Sang Hoon Kim; Byeong-Gon Na; Sung-Gyu Lee
Journal:  Ann Surg Treat Res       Date:  2021-06-30       Impact factor: 1.859

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.